ETROLIZUMAB COMPARED WITH ADALIMUMAB OR PLACEBO AS INDUCTION THERAPY FOR ULCERATIVE COLITIS: RESULTS FROM THE RANDOMIZED, PHASE 3 HIBISCUS I & II TRIALS
Iris Dotan 1
Julian Panés 2
Aaron Duvall 3
Yoram Bouhnik 4
Graham Radford-Smith 5
Peter D.R. Higgins 6
Daniel S. Mishkin 7
Pablo Arrisi
Astrid Scalori
Young Oh
Swati Tole
Akiko Chai
Kirsten Chamberlain-James
Stuart Lacey
Jacqueline McBride
David T. Rubin
1 Rabin Medical Center,Petah Tikva,Israel
2 Hospital Clinic Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
3 Tyler Research Institute,Tyler,United States
4 Inserm et Université Paris Diderot,Paris,France
5 Royal Brisbane and Women’s Hospital,Herston,Australia
6 University of Michigan,Ann Arbor,United States
7 Atrius Health,Boston,United States
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing